Tokyo Tape
Sign in
← Falco Holdings

Quarterly report · Q1

4671.TEDINET S100RP4T
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥10.6bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥46.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥11.6bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥249m2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥681m2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥303m2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥3.3bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥769m2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥292m2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥748m2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥124m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥442m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥124m2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥442m2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥37.1bnat 2023-06-30Cons.Assets
Total assets¥38.9bnat 2023-03-31Cons.Assets
Total assets¥38.2bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥11.2bnat 2023-06-30Cons.Liabilities
Total liabilities¥12.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥26.0bnat 2023-06-30Cons.Net assets
Net assets / equity¥26.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥23.6bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥9.6bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥12.6bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥11.072023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥215.292022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥42.322022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥11.052023-04-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥214.032022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥42.252022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio69.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio68.2%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio61.5%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30¥0
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30¥0
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥145m
jpcrp040300-q1r_E04982-000Clinical Testing Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥6.6bn
jpcrp040300-q1r_E04982-000Clinical Testing Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥6.6bn
jpcrp040300-q1r_E04982-000Clinical Testing Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥0
jpcrp040300-q1r_E04982-000Clinical Testing Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥348m
jpcrp040300-q1r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥0
jpcrp040300-q1r_E04982-000Dispensing Pharmacy Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥55m
jpcrp040300-q1r_E04982-000ICT Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥190m
jpcrp040300-q1r_E04982-000ICT Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥190m
jpcrp040300-q1r_E04982-000ICT Businessreportable segmentsegment profit2023-04-01 → 2023-06-30−¥8m
—segment totalrevenue2023-04-01 → 2023-06-30¥10.6bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥10.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥0
—segment totalsegment profit2023-04-01 → 2023-06-30¥395m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥4m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥4m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥108m
jpcrp040300-q1r_E04982-000Clinical Testing Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥7.6bn
jpcrp040300-q1r_E04982-000Clinical Testing Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥7.6bn
jpcrp040300-q1r_E04982-000Clinical Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥3m
jpcrp040300-q1r_E04982-000Clinical Testing Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥855m
jpcrp040300-q1r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥3.9bn
jpcrp040300-q1r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.9bn
jpcrp040300-q1r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E04982-000Dispensing Pharmacy Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6m
jpcrp040300-q1r_E04982-000ICT Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥102m
jpcrp040300-q1r_E04982-000ICT Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥102m
jpcrp040300-q1r_E04982-000ICT Businessreportable segmentsegment profit2022-04-01 → 2022-06-30−¥73m
—segment totalrevenue2022-04-01 → 2022-06-30¥11.6bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥11.6bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥4m
—segment totalsegment profit2022-04-01 → 2022-06-30¥789m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 358
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant57900
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant57900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0051
Cash and depositsPrior1YearInstant12603000000JPY
Cash and depositsCurrentQuarterInstant9613000000JPY
Notes and accounts receivable tradePrior1YearInstant6651000000JPY
Notes and accounts receivable tradeCurrentQuarterInstant5967000000JPY
Merchandise and finished goodsPrior1YearInstant833000000JPY
Merchandise and finished goodsCurrentQuarterInstant1228000000JPY
Work in processPrior1YearInstant66000000JPY
Work in processCurrentQuarterInstant68000000JPY
Raw materials and suppliesPrior1YearInstant556000000JPY
Raw materials and suppliesCurrentQuarterInstant522000000JPY
Other caPrior1YearInstant1996000000JPY
Other caCurrentQuarterInstant2290000000JPY
Allowance for doubtful accounts caPrior1YearInstant-1000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-0JPY
Current assetsPrior1YearInstant22706000000JPY
Current assetsCurrentQuarterInstant19690000000JPY
Buildings and structuresPrior1YearInstant9435000000JPY
Buildings and structuresCurrentQuarterInstant9359000000JPY
Accumulated depreciation buildings and structuresPrior1YearInstant-4761000000JPY
Accumulated depreciation buildings and structuresCurrentQuarterInstant-4756000000JPY
Buildings and structures netPrior1YearInstant4674000000JPY
Buildings and structures netCurrentQuarterInstant4603000000JPY
LandPrior1YearInstant4924000000JPY
LandCurrentQuarterInstant4893000000JPY
Lease assets ppePrior1YearInstant1290000000JPY
Lease assets ppeCurrentQuarterInstant1253000000JPY
Accumulated depreciation lease assets ppePrior1YearInstant-906000000JPY
Accumulated depreciation lease assets ppeCurrentQuarterInstant-937000000JPY
Lease assets net ppePrior1YearInstant383000000JPY
Lease assets net ppeCurrentQuarterInstant316000000JPY
Other ppePrior1YearInstant4395000000JPY
Other ppeCurrentQuarterInstant4442000000JPY
Accumulated depreciation other ppePrior1YearInstant-3655000000JPY
Accumulated depreciation other ppeCurrentQuarterInstant-3681000000JPY
Other net ppePrior1YearInstant739000000JPY
Other net ppeCurrentQuarterInstant760000000JPY
Property plant and equipmentPrior1YearInstant10722000000JPY
Property plant and equipmentCurrentQuarterInstant10573000000JPY
GoodwillPrior1YearInstant12000000JPY
GoodwillCurrentQuarterInstant8000000JPY
Other iaPrior1YearInstant365000000JPY
Other iaCurrentQuarterInstant337000000JPY
Intangible assetsPrior1YearInstant378000000JPY
Intangible assetsCurrentQuarterInstant346000000JPY
Investment securitiesPrior1YearInstant2618000000JPY
Investment securitiesCurrentQuarterInstant4142000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass